We Dissect Protocols

Rpmi 1640 medium

Manufactured by Thermo Fisher Scientific
34 914 citations
Sourced in United States, China, United Kingdom, Germany, Japan, France, Canada, Italy, Australia, Switzerland, Belgium, Spain, Sweden, New Zealand, Israel, Denmark, Austria, Brazil, Ireland, Netherlands, India, Poland, Holy See (Vatican City State), Macao, Norway, Morocco, Sao Tome and Principe, Singapore, Cameroon, Argentina, Hong Kong, Taiwan, Province of China, Palestine, State of, Finland, Colombia, United Arab Emirates, Moldova, Republic of, Panama, Uruguay, Thailand, Hungary, Mongolia, Gabon, Tunisia, Azerbaijan
About the product

RPMI 1640 medium is a commonly used cell culture medium developed at Roswell Park Memorial Institute. It is a balanced salt solution that provides essential nutrients, vitamins, and amino acids to support the growth and maintenance of a variety of cell types in vitro.

Automatically generated - may contain errors

Market Availability & Pricing

RPMI 1640 Medium is an official product offered by Thermo Fisher Scientific and available through their authorized distributors. Pricing typically ranges from $15.13 for 100 mL to $584.00 for 10 L, depending on the volume and formulation.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

34 914 protocols using «rpmi 1640 medium»

1

Expansion and Differentiation of HSPCs

2025
On days 0~5, hematopoietic stem and progenitor cells (HSPCs) were massively amplified in StemPro™−34 SFM medium (10639011; life technologies) supplemented with 1% penicillin–streptomycin, 10% FBS (SE100-B; VISTECH), 1% GlutaMAX (35050061; Gibco), 50 ng/mL G-CSF (10007-HNCH-5; Sino Biological), and 20 ng/mL hIL3. On days 5~9, the cells were cultured in RPMI 1640 medium (C11875500BT; ThermoFisher) supplemented with 1% penicillin–streptomycin, 10% FBS, 1% GlutaMAX, and 100 ng/mL G-CSF. The medium was changed every 2~–3 days. Cells differentiated up to day 9 were collected for subsequent experimental assays.
+ Open protocol
+ Expand
2

Cytokine evaluation of lymphocytes

2025
To this end, 14 days after the last vaccination, three mice in each experimental group were euthanized and lymphocytes were harvested under aseptic conditions for cytokine evaluation [47 ]. The harvested lymphocytes were cultivated in RPMI-1640 medium (Gibco) supplemented with 20% fetal bovine serum (FBS). Next, 500 μL of extracted lymphocyte suspension of each mouse was cultured in two wells of a 24-well cell culture plate, challenged with 50 μg of crude antigen prepared [48 (link)], and the volume of each well was reached to 1 mL using complete RPMI medium. The plates were incubated for 48–72 h at 37°C with 5% CO2. Finally, the supernatant of each well was harvested and centrifuged (3000 rpm, 10 min); then, interferon γ (IFN-γ) and interleukin 4 (IL-4) cytokines were measured in triplicate by commercial ELISA kits (Karmania Pars Gene, Kerman, Iran), based on the manufacturer's protocol.
+ Open protocol
+ Expand
3

Murine Lymphocyte Isolation and IFN-γ/IL-2 ELISpot Assay

2025
After the mice were euthanized and soaked with 75% ethanol for 1 min, splenic tissues were harvested into the 10‐cm cell‐culture dish. Four to five milliliters of mice lymphocyte isolate (cat#: 7211011, Dakewe) was taken, and the splenic tissues were grinded using the 2‐mL syringe plunger, followed by filtration with the 40‐µm filter. Thereafter, we added the spleen cell suspension into the 15‐mL centrifuge tube at once, introduced 1 mL RPMI‐1640 medium (cat#: 42401042, Gibco), and centrifuged the mixture at 800 × g at 4°C for a 30‐min duration. Afterward, the solution within centrifuge tube was separated in 4 layers, including the RPMI‐1640 medium, lymphocyte, separation medium layers, and the layer containing red blood cells as well as cell debris, from the top down. After aspiration, we added the lymphocyte layer to 10 mL RPMI‐1640 medium, centrifuged the mixture for a 10‐min period at 250 × g and 4°C to harvest lymphocytes, and suspended cells within serum‐free medium. Mouse IFN‐γ (cat#: 3511–4hpw‐2, Mabtech) and IL‐2 ELISpot plus kits (cat#: 3441–4hpw‐2, Mabtech) were then adopted for detecting interferon gamma (IFN‐γ)‐ and interleukin (IL)‐2‐positive cells. 96‐Well PVDF plates were rinsed by PBS (200 µL) twice, prior to 2‐h blocking using RPMI‐1640 medium that contained 10% fetal bovine serum under 25°C. We later added the separated lymphocytes (2.5 × 105 cells) into each well and treated them with 1 µg/mL of S protein peptide pools from the EG.5 (GenScript, Nanjing, China), XBB.1.5 (cat#: DD9123, Vazyme), and BA.4/5 (cat#: DD 9125, Vazyme) subvariants for 24 h under 37°C. Lymphocytes were later subjected to 2‐h incubation using anti‐Mouse IFN‐γ or anti‐mouse IL‐2 antibody under ambient temperature and then 1‐h incubation using streptavidin‐horseradish peroxidase (1:1000). Cells were later washed before 5‐min incubation using 3,5,‐tetramethylbenzidine (TMB, 100 µL) substrate solution until visible spots appeared. Employ the ImmunoSpot S6 Universal spot counter for imaging and counting of IFN‐γ‐secreting cell spots.
+ Open protocol
+ Expand
4

Splenocyte Activation and IFN-γ Measurement

2025
The splenocytes were cultured in 200 µL RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated FBS (Gibco), 2 mM L-glutamine (Gibco), 1% non-essential amino acids (Gibco), 1 mM sodium pyruvate (Gibco) and 1% HEPES 1M (Gibco) and 1% penicillin-streptomycin (10,000 U/mL, Gibco) with phorbol 12-myristate 13-acetate (PMA, 125 ng/mL final; Sigma, P8139) and ionomycin (1 µg/mL final; Sigma, I0634) and GolgiStop (BD, 1/1,500) to increase intracellular protein transport. and were kept for 4 hours at 37°C under an atmosphere of 5% CO2. Control conditions were obtained without PMA and ionomycin. The cells were then washed twice in staining buffer and incubated with the antibodies anti-CD3-Pacific Blue (BD), anti-CD8, anti-NK1.1 and anti-NKp46 (clone 29A1.4 BioLegend) for 45 min at 4°C. The cells were washed twice, fixed and permeabilized with Cytofix/Cytoperm (BD). The cells were washed twice in Perm/Wash (BD) and stained by incubation with anti-IFN-γ (BD) antibody for 30 min at 4°C. Cells were washed twice and data were acquired using the LSR2UV Flow Cytometer.
+ Open protocol
+ Expand
5

Tumor Tissue Dissociation for Flow Cytometry

2025
Tumor tissue that was not used for genetic testing or histology was mechanically dissociated for flow cytometric analysis with the BD Medimachine system (BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturer's protocol. Briefly, tumor tissue was resuspended in RPMI 1640 Medium (Thermo Fisher Scientific, Waltham, MA, USA) or Dulbecco's phosphate-buffered saline (D-PBS; Sigma-Aldrich, St. Louis, MO, USA). Disposable Medicon capsules with a 50-µm steel mesh with about 100 hexagonal bore-holes framed by six microblades (BD Biosciences) were filled with 1 mL of tumor tissue suspension. The Medicons were inserted into the BD Medimachine and run for 1 minute at a rotation speed of approximately 100 rpm. The aspirated cell suspension was passed through a 70-µm Filcon filter (BD Biosciences). Tumor cell suspensions were used immediately for flow cytometric analysis.
+ Open protocol
+ Expand

Top 5 most cited protocols using «rpmi 1640 medium»

1

PC12 Cell Culture and Differentiation

Because of the clonal instability of the PC12 cell line (Fujita et al. 1989 (link)), the experiments were performed on cells that had undergone fewer than five passages, and all studies were repeated several times with different batches of cells. As described previously (Crumpton et al. 2000a (link); Qiao et al. 2003 (link); Song et al. 1998 (link)), PC12 cells (1721-CRL; American Type Culture Collection, Manassas, VA) were seeded onto 100-mm poly-d-lysine-coated plates in RPMI-1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10% inactivated horse serum (Sigma Chemical Co., St. Louis, MO), 5% fetal bovine serum (Sigma Chemical Co.), and 50 μg/mL penicillin streptomycin (Invitrogen). Cells were incubated with 7.5% CO2 at 37°C, and the medium was changed every 2 days. For studies in the undifferentiated state, cells were seeded at varying densities so that, regardless of the total time of incubation, the cells would reach a final confluence of 60–70%. Twenty-four hours after seeding, the medium was changed to include the various test substances: chlorpyrifos (Chem Service, West Chester, PA), diazinon (Chem Service), parathion (Chem Service), physostigmine (Sigma Chemical Co.), dieldrin (Chem Service), or NiCl2 (Sigma Chemical Co.). Because of their poor water solubility, the pesticides were dissolved in dimethyl sulfoxide (Sigma Chemical Co.), achieving a final concentration of 0.1% in the culture medium; accordingly, all cultures included this vehicle, which had no effect on the PC12 cells (Qiao et al. 2001 (link), 2003 (link); Song et al. 1998 (link)).
For studies in differentiating cells, 3 × 106 cells were seeded; 24 hr later, the medium was changed to include 50 ng/mL 2.5 S murine NGF (Invitrogen), and each culture was examined under a microscope to verify the subsequent outgrowth of neurites. The test agents were added concurrently with the start of NGF treatment.
+ Open protocol
+ Expand

Corresponding organizations : Duke University

2

PC12 Cell Culture and Differentiation

As described previously (Crumpton et al. 2000 (link); Qiao et al. 2003 (link); Song et al. 1998 ), PC12 cells (1721-CRL; American Type Culture Collection, Rockville, MD) were grown in RPMI-1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10% inactivated horse serum (Sigma Chemical Co., St. Louis, MO), 5% fetal bovine serum (Sigma), and 50 μg/mL penicillin–streptomycin (Invitrogen); cells were incubated with 7.5% CO2 at 37°C, and the medium was changed every 2 days. Because of the clonal instability of the PC12 cell line (Fujita et al. 1989 (link)), the experiments were performed on cells that had undergone fewer than five passages, and studies were repeated several times with different batches of cells. For studies in the undifferentiated state, 3–6 × 106 cells were seeded onto 100-mm poly-l-lysine–coated plates, and 24 hr later the medium was changed to include 5 or 50 μM CPF (purity, 98%; Chem Service, West Chester, PA). CPF was dissolved in dimethyl sulfoxide (DMSO), achieving final DMSO concentrations of 0.1–1% in the culture medium, and the corresponding control samples contained equivalent DMSO concentrations. Preliminary studies were conducted to verify that these concentrations of DMSO had no effect on the measured parameters in PC12 cells (data not shown), in agreement with earlier work (Qiao et al. 2001 (link), 2003 (link); Song et al. 1998 ).
For studies during differentiation, 3.5 × 106 cells were seeded; 24 hr later the medium was changed to include 50 ng/mL NGF (Sigma), and over the ensuing week, each culture was examined under a microscope to verify the outgrowth of neurites. CPF or physostigmine (Sigma) was added either simultaneously with the addition of NGF or after a 4-day NGF pretreatment.
+ Open protocol
+ Expand

Corresponding organizations : Duke University, Duke Medical Center, Duke University Hospital

3

Isolation and Culture of Human Endometrial Organoids

Endometrial/decidual/carcinoma tissues were chopped using scalpels into approximately 0.5 mm3 cubes and enzymatically digested in 20-30 mL 1.25U/mL Dispase II (Sigma, D4693)/ 0.4mg/mL collagenase V (Sigma, C-9263) solution in RPMI 1640 medium (ThermoFisher Scientific, 21875-034)/10% FCS (Biosera, FB-1001) with gentle shaking at 37°C for 30-60 min. The supernatant was passed through one or more 100 μm cell sieves (Corning, 431752) and the sieve washed several times with medium. The flow-through was collected for stromal cell culture in Advanced DMEM/F12 (ThermoFisher Scientific, 12634010) +10%FBS+pen/strep (Sigma, P0781) +L-glutamine (Sigma, 25030-024) for several days and subsequent analysis. The sieves were inverted over a petri dish and retained glandular elements were backwashed from the sieve membranes, pelleted by centrifugation and resuspended in ice cold Matrigel (Corning, 536231) at a ratio of 1:20 (vol:vol). 20 μL drops of Matrigel-cell suspension were plated into 48-well plate (Costar, 3548), allowed to set at 37°C and overlaid with 250 μL organoid Expansion Medium (ExM). See Supplementary Table 3 for ExM composition. The medium was changed every 2-3 d. Cultures were passaged by manual pipetting every 7-10 d. For freezing organoids, Matrigel was removed using Cell Recovery Solution (Corning, 354253) and organoids were resuspended in Recovery cell culture freezing medium (ThermoFisher Scientific, 12648-010). A step-by-step protocol of the derivation and maintenance of human endometrial organoid cultures can be found at Nature Protocol Exchange59 (link).
+ Open protocol
+ Expand

Corresponding organizations : University of Cambridge, Addenbrooke's Hospital, The Royal Free Hospital, Anthony Nolan, University College London, University of Warwick, MRC Centre for Reproductive Health, University of Edinburgh, Wellcome/Cancer Research UK Gurdon Institute, Wellcome/MRC Cambridge Stem Cell Institute, Medical Research Council

4

Investigating miR-187's Impact on NSCLC

The NSCLC lines (A549, H1975, NCI-H460 and SPC-A-1) and human normal lung epithelial cells (16HBE) were purchased from American Type Culture Collection (ATCC, MD, USA). A549 cells were cultured in DMEM F12 medium (Gibco, NY, USA). H1975, NCI-H460 and SPC-A-1 cells were cultured in RPMI-1640 medium (Gibco). All the cells were maintained in medium supplemented with 10% fetal bovine serum (FBS, Gibco) and cultured at 37°C in an atmosphere with 5% CO2. miR-187 mimic and negative control (NC) constructs were purchased from GenePharma (Shanghai, China). To assess the effect of miR-187 on cell proliferation, the miR-187 mimic was transfected into A549 and SPC-A-1 cells using Lipofectamine 2000 (Invitrogen, Thermo Fisher Scientific, USA) according to the manufacturer’s protocol.
+ Open protocol
+ Expand

Corresponding organizations : Southern Medical University, Guangzhou Chest Hospital

5

Isolation and Culture of Human Endometrial Organoids

Endometrial/decidual/carcinoma tissues were chopped using scalpels into approximately 0.5 mm3 cubes and enzymatically digested in 20-30 mL 1.25U/mL Dispase II (Sigma, D4693)/ 0.4mg/mL collagenase V (Sigma, C-9263) solution in RPMI 1640 medium (ThermoFisher Scientific, 21875-034)/10% FCS (Biosera, FB-1001) with gentle shaking at 37°C for 30-60 min. The supernatant was passed through one or more 100 μm cell sieves (Corning, 431752) and the sieve washed several times with medium. The flow-through was collected for stromal cell culture in Advanced DMEM/F12 (ThermoFisher Scientific, 12634010) +10%FBS+pen/strep (Sigma, P0781) +L-glutamine (Sigma, 25030-024) for several days and subsequent analysis. The sieves were inverted over a petri dish and retained glandular elements were backwashed from the sieve membranes, pelleted by centrifugation and resuspended in ice cold Matrigel (Corning, 536231) at a ratio of 1:20 (vol:vol). 20 μL drops of Matrigel-cell suspension were plated into 48-well plate (Costar, 3548), allowed to set at 37°C and overlaid with 250 μL organoid Expansion Medium (ExM). See Supplementary Table 3 for ExM composition. The medium was changed every 2-3 d. Cultures were passaged by manual pipetting every 7-10 d. For freezing organoids, Matrigel was removed using Cell Recovery Solution (Corning, 354253) and organoids were resuspended in Recovery cell culture freezing medium (ThermoFisher Scientific, 12648-010). A step-by-step protocol of the derivation and maintenance of human endometrial organoid cultures can be found at Nature Protocol Exchange59 (link).
+ Open protocol
+ Expand

Corresponding organizations : University of Cambridge, Addenbrooke's Hospital, The Royal Free Hospital, Anthony Nolan, University College London, University of Warwick, MRC Centre for Reproductive Health, University of Edinburgh, Wellcome/Cancer Research UK Gurdon Institute, Wellcome/MRC Cambridge Stem Cell Institute, Medical Research Council

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Protocol search & design
(papers, patents, application notes)
2. Protocol validation
(from literature and MDAR)
3. Lab Product search
4. Product validation from literature
5. Troubleshoot product/ protocol
6. Instant figure generation New
Want to copy this response? Create your account to unlock copy/paste and export options.